Add to ORKGThis article was published in the Fall 2009 issue of the Journal of Undergraduate Researc
Lung cancer accounts for about 27% of all cancer deaths and is by far the leading cause of cancer de...
Cancers of epithelial origin are responsible for the majority of cancer-related deaths in the USA. U...
Background: Drug screening for the identification of compounds with anticancer activity is commonly ...
This article was published in the Fall 2009 issue of the Journal of Undergraduate Researc
Efficient cancer drugs need to selectively destroy tumour cells without harming healthy cells. Exist...
ABSTRACT. Management of cancer is one of the challenging problems in medical practice as there are n...
The advent of molecular targeted agents is changing the treatment of solid tumors. In non-small-cell...
Lung cancer is the second most common cancer in both men and women around the world, and 85% of it i...
MSc (Pharmaceutics), North-West University, Potchefstroom Campus, 2019Small cell lung cancer (SCLC) ...
During cancer progression, cells undergo genetic mutations and epigenetic alterations that, in coord...
A subset of cells within solid tumors become highly enlarged and enter a state of dormancy (sustaine...
Lung cancer is the main cause of cancer death worldwide, with lung squamous cell carcinoma (LUSC) be...
Background Cancer stem cells represent a population of immature tumor cells found in most solid tu-m...
Cell-based assays in multiwell plates are widely used for radiosensitivity and chemosensitivity asse...
Lung cancer remains the most common cause of cancer-related deaths globally. The work in this thesis...
Lung cancer accounts for about 27% of all cancer deaths and is by far the leading cause of cancer de...
Cancers of epithelial origin are responsible for the majority of cancer-related deaths in the USA. U...
Background: Drug screening for the identification of compounds with anticancer activity is commonly ...
This article was published in the Fall 2009 issue of the Journal of Undergraduate Researc
Efficient cancer drugs need to selectively destroy tumour cells without harming healthy cells. Exist...
ABSTRACT. Management of cancer is one of the challenging problems in medical practice as there are n...
The advent of molecular targeted agents is changing the treatment of solid tumors. In non-small-cell...
Lung cancer is the second most common cancer in both men and women around the world, and 85% of it i...
MSc (Pharmaceutics), North-West University, Potchefstroom Campus, 2019Small cell lung cancer (SCLC) ...
During cancer progression, cells undergo genetic mutations and epigenetic alterations that, in coord...
A subset of cells within solid tumors become highly enlarged and enter a state of dormancy (sustaine...
Lung cancer is the main cause of cancer death worldwide, with lung squamous cell carcinoma (LUSC) be...
Background Cancer stem cells represent a population of immature tumor cells found in most solid tu-m...
Cell-based assays in multiwell plates are widely used for radiosensitivity and chemosensitivity asse...
Lung cancer remains the most common cause of cancer-related deaths globally. The work in this thesis...
Lung cancer accounts for about 27% of all cancer deaths and is by far the leading cause of cancer de...
Cancers of epithelial origin are responsible for the majority of cancer-related deaths in the USA. U...
Background: Drug screening for the identification of compounds with anticancer activity is commonly ...